Aozhi Dai
Level 5, 99 Commercial Road
Melbourne, VIC 3004, Australia
Melbourne, VIC 3004, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Activator protein-1 (AP-1) inhibition prevents endothelial to mesenchymal transition in diabetes-associated atherosclerosis: a translational study.
Journal: Cardiovascular diabetology
Published: July 15, 2025
Induced Genetic Deletion of Cell Division Autoantigen 1 in Adulthood Attenuates Diabetes-Associated Renal Fibrosis.
Journal: International journal of molecular sciences
Published: January 22, 2025
Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes.
Journal: Antioxidants (Basel, Switzerland)
Published: February 13, 2024
Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosis.
Journal: Scientific reports
Published: March 16, 2022
Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease.
Journal: Clinical science (London, England : 1979)
Published: September 02, 2021
Ultrasound combined with microbubbles enhances the renoprotective effects of methylprednisolone in rats with adriamycin-induced nephropathy.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 08, 2020
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
Journal: Diabetologia
Published: January 29, 2019
Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species.
Journal: Frontiers in physiology
Published: November 23, 2018
Last Updated: 09/26/2026